UK markets closed

Bicycle Therapeutics plc (BCYC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
22.73+0.21 (+0.93%)
At close: 04:00PM EDT
22.73 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Loading interactive chart…
  • Business Wire

    Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting

    CAMBRIDGE, England & BOSTON, April 24, 2024--Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the acceptance of two abstracts for poster presentation at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting, taking place May 31-June 4 in Chicago.

  • Business Wire

    Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

    CAMBRIDGE, England & BOSTON, April 02, 2024--Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on April 9, 2024, at 11 a.m. ET.

  • Business Wire

    Bicycle Therapeutics to Present at the AACR Annual Meeting 2024

    CAMBRIDGE, England & BOSTON, March 05, 2024--Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the acceptance of three abstracts for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024, taking place in San Diego on April 5-10.